Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for SYBX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 13.48M
March 31, 2026 14.61M
December 31, 2025 15.45M
September 30, 2025 16.56M
June 30, 2025 17.37M
March 31, 2025 17.97M
December 31, 2024 19.83M
September 30, 2024 20.76M
June 30, 2024 21.64M
March 31, 2024 36.06M
December 31, 2023 75.55M
September 30, 2023 66.25M
June 30, 2023 79.28M
March 31, 2023 93.44M
December 31, 2022 110.86M
September 30, 2022 128.24M
June 30, 2022 143.54M
March 31, 2022 159.31M
December 31, 2021 174.74M
September 30, 2021 190.54M
June 30, 2021 156.88M
March 31, 2021 135.74M
December 31, 2020 143.84M
September 30, 2020 148.35M
June 30, 2020 159.39M
Date Value
March 31, 2020 171.14M
December 31, 2019 188.57M
September 30, 2019 202.41M
June 30, 2019 214.94M
March 31, 2019 145.00M
December 31, 2018 140.34M
September 30, 2018 152.05M
June 30, 2018 161.07M
March 31, 2018 142.66M
December 31, 2017 99.70M
September 30, 2017 104.47M
June 30, 2017 48.12M
March 31, 2017 60.61M
December 31, 2016 20.04M
September 30, 2016 71.74M
June 30, 2016 77.17M
March 31, 2016 82.12M
December 31, 2015 90.92M
September 30, 2015 38.09M
June 30, 2015 42.19M
March 31, 2015 40.55M
December 31, 2014 9.825M
September 30, 2014
June 30, 2014
March 31, 2014 21.94M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 172.69M
Amgen, Inc. 95.64B
Anika Therapeutics, Inc. 183.47M
BioCryst Pharmaceuticals, Inc. 557.85M
Imunon, Inc. 14.99M

Total Assets (Quarterly) Related Metrics